Publications by authors named "Muhammad Alamgeer"

Claim this Profile
O
Oncology and intensive care doctors' perception of intensive care admission of cancer patients: A cross-sectional national survey.
Swarup Padhi, Prajwol Shrestha, Muhammad Alamgeer, Amanda Stevanovic, Deme Karikios

Aust Crit Care· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atherosclerotic Cardiovascular Events in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Retrospective Cohort Study.
Sean Tan, Ella Spear, Nikhita Sane, Jasmine Chan, Adam J Nelson, Muhammad Alamgeer

Heart Lung Circ· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FRailty in Australian patients admitted to Intensive care unit after eLective CANCER-related SURGery: a retrospective multicentre cohort study (FRAIL-CANCER-SURG study).
Ryan R Ling, Ryo Ueno, Muhammad Alamgeer, Krishnaswamy Sundararajan, Raghav Sundar

Br J Anaesth· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitor therapy for advanced cutaneous squamous cell carcinoma in Australia: a retrospective real world cohort study.
Luke S McLean, Annette M Lim, Mathias Bressel, Jenny Lee, Rahul Ladwa, Muhammad Alamgeer

Med J Aust· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frailty and long-term survival among patients in Australian intensive care units with metastatic cancer (FRAIL-CANCER study): a retrospective registry-based cohort study.
Muhammad Alamgeer, Ryan Ruiyang Ling, Ryo Ueno, Krishnaswamy Sundararajan, Raghav Sundar

Lancet Healthy Longev· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Analysis of Clinical Characteristics and Survival Outcomes in Patients With Extensive-Stage SCLC Treated With First-Line Chemoimmunotherapy.
Yang Wang, Jared Mathai, Muhammad Alamgeer, Sagun Parakh, Eldho Paul

JTO Clin Res Rep· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MYC drives platinum resistant SCLC that is overcome by the dual PI3K-HDAC inhibitor fimepinostat.
Jasmine Chen, Aleks C Guanizo, W Samantha N Jakasekara, Chaitanya Inampudi, Quinton Luong, Muhammad Alamgeer

J Exp Clin Cancer Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumour DNA (ctDNA) as a Predictor of Clinical Outcome in Non-Small Cell Lung Cancer Undergoing Targeted Therapies: A Systematic Review and Meta-Analysis.
Farzana Y Zaman, Ashwin Subramaniam, Afsana Afroz, Zarka Samoon, Daniel Gough, Muhammad Alamgeer

Cancers (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment outcomes of standard (high dose) cisplatin and non-standard chemotherapy for locally advanced head and neck cancer.
Muhammad Alamgeer, Andrew Coleman, Lachlan McDowell, Charles Giddings, Adnan Safdar

Cancer Rep (Hoboken)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the impact of COVID-19-induced coagulopathy.
Ashwin Subramaniam, Muhammad Alamgeer

Ann Acad Med Singap· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary study highlights the potential of immune checkpoint inhibitors in sarcomatoid mesothelioma.
Natasha K Brockwell, Muhammad Alamgeer, Beena Kumar, Gareth Rivalland, Thomas John

Transl Lung Cancer Res· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Technological and Therapeutic Advances in Advanced Small Cell Lung Cancer.
Caroline Lum, Muhammad Alamgeer

Cancers (Basel)· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep multi-region whole-genome sequencing reveals heterogeneity and gene-by-environment interactions in treatment-naive, metastatic lung cancer.
Tracy L Leong, Velimir Gayevskiy, Daniel P Steinfort, Marc R De Massy, Alvaro Gonzalez-Rajal, Muhammad Alamgeer

Oncogene· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy.
Kieren D Marini, David R Croucher, Rachael A McCloy, Vijesh Vaghjiani, Alvaro Gonzalez-Rajal, Muhammad Alamgeer

Sci Transl Med· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase IIa study of HA-irinotecan, formulation of hyaluronic acid and irinotecan targeting CD44 in extensive-stage small cell lung cancer.
Muhammad Alamgeer, D Neil Watkins, Ilia Banakh, Beena Kumar, Daniel J Gough

Invest New Drugs· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-Dose Histone Deacetylase Inhibitor Treatment Leads to Tumor Growth Arrest and Multi-Lineage Differentiation of Malignant Rhabdoid Tumors.
Andrea Muscat, Dean Popovski, W Samantha N Jayasekara, Fernando J Rossello, Melissa Ferguson, Muhammad Alamgeer

Clin Cancer Res· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic characterisation of small cell lung cancer patient-derived xenografts generated from endobronchial ultrasound-guided transbronchial needle aspiration specimens.
Tracy L Leong, Kieren D Marini, Fernando J Rossello, Samantha N Jayasekara, Prudence A Russell, Muhammad Alamgeer

PLoS One· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.
Sweet Ping Ng, Steven David, Muhammad Alamgeer, Vinod Ganju

Int J Radiat Oncol Biol Phys· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Evolution of Therapies in Non-Small Cell Lung Cancer.
Vishal Boolell, Muhammad Alamgeer, David N Watkins, Vinod Ganju

Cancers (Basel)· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in aldehyde dehydrogenase-1 expression during neoadjuvant chemotherapy predict outcome in locally advanced breast cancer.
Muhammad Alamgeer, Vinod Ganju, Beena Kumar, Jane Fox, Stewart Hart

Breast Cancer Res· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer.
Muhammad Alamgeer, Vinod Ganju, Anette Szczepny, Prudence A Russell, Zdenka Prodanovic

Thorax· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer stem cells in lung cancer: Evidence and controversies.
Muhammad Alamgeer, Craig D Peacock, William Matsui, Vinod Ganju, D Neil Watkins

Respirology· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel therapeutic targets in non-small cell lung cancer.
Muhammad Alamgeer, Vinod Ganju, D Neil Watkins

Curr Opin Pharmacol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis